HealthEquity (NASDAQ:HQY – Get Free Report) is set to issue its quarterly earnings data after the market closes on Monday, December 9th. Analysts expect the company to announce earnings of $0.71 per share for the quarter. HealthEquity has set its FY25 guidance at 2.98-3.14 EPS and its FY 2025 guidance at 2.980-3.140 EPS.Parties that are interested in registering for the company’s conference call can do so using this link.
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. On average, analysts expect HealthEquity to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
HealthEquity Trading Down 0.9 %
HQY stock opened at $101.54 on Monday. The firm’s fifty day simple moving average is $90.16 and its two-hundred day simple moving average is $82.81. The stock has a market capitalization of $8.87 billion, a price-to-earnings ratio of 84.62, a price-to-earnings-growth ratio of 1.59 and a beta of 0.52. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity has a twelve month low of $62.10 and a twelve month high of $105.82.
Insider Buying and Selling at HealthEquity
Analysts Set New Price Targets
A number of analysts have weighed in on the company. BTIG Research upped their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. The Goldman Sachs Group initiated coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Barrington Research reissued an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $107.23.
Check Out Our Latest Stock Report on HealthEquity
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
- Five stocks we like better than HealthEquity
- What is the Dogs of the Dow Strategy? Overview and Examples
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What is a Low P/E Ratio and What Does it Tell Investors?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.